XNCR Q3 2023 Earnings — Xencor, Inc. Revenue & Financial Results | Market Cap Arena

XNCRXencor, Inc.

$890M

Q3 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$59M+116.7% YoY

Gross Profit

-$6M-9.8% margin

Operating Income

-$18M-30.9% margin

Net Income

-$24M-41.0% margin

EPS (Diluted)

$-0.40

QoQ Revenue Growth

+30.0%

Cash Flow

Operating Cash Flow

-$27M

Free Cash Flow

-$31M

Stock-Based Comp.

$13M

Balance Sheet

Total Assets

$778M

Total Liabilities

$109M

Stockholders' Equity

$669M

Cash & Equivalents

$53M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$59M	$27M	+116.7%
Gross Profit	-$6M	-$26M	+77.8%
Operating Income	-$18M	-$38M	+52.4%
Net Income	-$24M	-$33M	+25.9%

Revenue Segments

Milestone

$46M76%

Royalty

$15M24%